These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21772033)

  • 1. Uncovering the role of invariant chain in controlling MHC class II antigen capture.
    Germain RN
    J Immunol; 2011 Aug; 187(3):1073-5. PubMed ID: 21772033
    [No Abstract]   [Full Text] [Related]  

  • 2. Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc. Natl. Acad. Sci. USA. 1991. 88: 3150-3154.
    Roche PA; Cresswell P
    J Immunol; 2011 Aug; 187(3):1076-80. PubMed ID: 21772034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A common set of factors control the expression of the MHC class II, invariant chain, and HLA-DM genes.
    Boss JM
    Microbes Infect; 1999 Sep; 1(11):847-53. PubMed ID: 10614001
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of aberrant association of DM with MHC class II subunits in the absence of invariant chain.
    Neumann J; König A; Koch N
    Int Immunol; 2007 Jan; 19(1):31-9. PubMed ID: 17105964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the HLA-DM interaction site on HLA-DR molecules.
    Doebele RC; Busch R; Scott HM; Pashine A; Mellins ED
    Immunity; 2000 Oct; 13(4):517-27. PubMed ID: 11070170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHC class II expression in human basophils: induction and lack of functional significance.
    Voskamp AL; Prickett SR; Mackay F; Rolland JM; O'Hehir RE
    PLoS One; 2013; 8(12):e81777. PubMed ID: 24349126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The invariant chain gene intronic enhancer shows homology to class II promoter elements.
    Moore BB; Cao ZA; McRae TL; Woo CH; Conley S; Jones PP
    J Immunol; 1998 Aug; 161(4):1844-52. PubMed ID: 9712052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DO increases bacterial superantigen binding to human MHC molecules by inhibiting dissociation of class II-associated invariant chain peptides.
    Pezeshki AM; Azar GA; Mourad W; Routy JP; Boulassel MR; Denzin LK; Thibodeau J
    Hum Immunol; 2013 Oct; 74(10):1280-7. PubMed ID: 23756162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of class II expression in monocytic cells after HIV-1 infection.
    Rakoff-Nahoum S; Chen H; Kraus T; George I; Oei E; Tyorkin M; Salik E; Beuria P; Sperber K
    J Immunol; 2001 Aug; 167(4):2331-42. PubMed ID: 11490022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical, invariant chain-independent role for H2-M in antigen presentation.
    Swier K; Brown DR; Bird JJ; Martin WD; Van Kaer L; Reiner SL
    J Immunol; 1998 Jan; 160(2):540-4. PubMed ID: 9551884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC class II expression in double mutant mice lacking invariant chain and DM functions.
    Kenty G; Martin WD; Van Kaer L; Bikoff EK
    J Immunol; 1998 Jan; 160(2):606-14. PubMed ID: 9551894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An αß T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science. 1996. 274: 209-219.
    Garcia KC; Degano M; Stanfield RL; Brunmark A; Jackson MR; Peterson PA; Teyton L; Wilson IA
    J Immunol; 2010 Dec; 185(11):6402-12. PubMed ID: 21084669
    [No Abstract]   [Full Text] [Related]  

  • 13. MHC class II-associated invariant chain peptide replacement by T cell epitopes: engineered invariant chain as a vehicle for directed and enhanced MHC class II antigen processing and presentation.
    Malcherek G; Wirblich C; Willcox N; Rammensee HG; Trowsdale J; Melms A
    Eur J Immunol; 1998 May; 28(5):1524-33. PubMed ID: 9603457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms underlying the lack of endogenous processing and CLIP-mediated binding of the invariant chain by HLA-DP
    Anczurowski M; Yamashita Y; Nakatsugawa M; Ochi T; Kagoya Y; Guo T; Wang CH; Rahman MA; Saso K; Butler MO; Hirano N
    Sci Rep; 2018 Mar; 8(1):4804. PubMed ID: 29555965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
    Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
    Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant chain.
    Mizuochi T; Yee ST; Kasai M; Kakiuchi T; Muno D; Kominami E
    Immunol Lett; 1994 Dec; 43(3):189-93. PubMed ID: 7721331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More efficient peptide binding to MHC class II molecules during cathepsin B digestion of Ii than after Ii release.
    Daibata M; Xu M; Humphreys RE; Reyes VE
    Mol Immunol; 1994 Mar; 31(4):255-60. PubMed ID: 8139580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complexes of two cohorts of CLIP peptides and HLA-DQ2 of the autoimmune DR3-DQ2 haplotype are poor substrates for HLA-DM.
    Fallang LE; Roh S; Holm A; Bergseng E; Yoon T; Fleckenstein B; Bandyopadhyay A; Mellins ED; Sollid LM
    J Immunol; 2008 Oct; 181(8):5451-5461. PubMed ID: 18832702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of cathepsin B from large yellow croaker (Pseudosciaena crocea) and its role in the processing of MHC class II-associated invariant chain.
    Li M; Li Q; Yang Z; Hu G; Li T; Chen X; Ao J
    Dev Comp Immunol; 2014 Aug; 45(2):313-20. PubMed ID: 24705226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of mouse mammary tumor virus superantigen with MHC class II during biosynthesis.
    Hsu PN; Wolf Bryant P; Sutkowski N; McLellan B; Ploegh HL; Huber BT
    J Immunol; 2001 Mar; 166(5):3309-14. PubMed ID: 11207286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.